Search research articles
Contact Us
Filters
Showing results (1-10 of 131) with videos related to
Page
of 14
Sort By:
Pharmacoeconomics
|
December 18, 2002
Generic clozapine: a cost-saving alternative to brand name clozapine?
Gordon Tse, Deborah Thompson, Ric M Procyshyn
Schizophrenia Research
|
April 6, 2004
Clozapine's effects on body weight and resting metabolic rate: a case series
Ric M Procyshyn, Anthony Chau, Gordon Tse
BMJ Case Reports
|
February 13, 2025
Acute dystonia following the two-injection start of aripiprazole once-monthly
Alexander Levit, Ric M Procyshyn, Kamyar Keramatian
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
December 14, 2002
The influence of dyslipidemia on the plasma protein and lipoprotein distribution of haloperidol
Ric M Procyshyn, Gina Tsai, Kishor M Wasan
Drug Development and Industrial Pharmacy
|
August 12, 2005
Competitive displacement of clozapine from plasma proteins in normolipidemic and hyperlipidemic plasma samples: clinical implications
Ric M Procyshyn, Tiffany Ho, Kishor M Wasan
Schizophrenia Research
|
February 27, 2004
Smoking, anticholinergics and schizophrenia
Ric M Procyshyn, Kaleena Patel, Deborah L Thompson
Drug Development and Industrial Pharmacy
|
November 25, 2005
The effects of competitive displacement on haloperidol's plasma distribution in normolipidemic and hyperlipidemic plasma
Ric M Procyshyn, Tiffany Ho, Kishor M Wasan
Journal of Psychiatry & Neuroscience : JPN
|
December 21, 2011
Adverse events associated with switching antipsychotics
Johnny Su, Alasdair M Barr, Ric M Procyshyn
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
January 15, 2002
Concomitant clozapine reduces smoking in patients treated with risperidone
Ric M Procyshyn, Gordon Tse, Osric Sin, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
October 27, 2004
Prevalence and outcomes of pharmaceutical industry-sponsored clinical trials involving clozapine, risperidone, or olanzapine
Ric M Procyshyn, Anthony Chau, Patricia Fortin, et al.
Page
of 14
Search research articles
Search
Showing results (1-10 of 131) with videos related to
Sort By:
Page
of 14
Pharmacoeconomics
|
December 18, 2002
Generic clozapine: a cost-saving alternative to brand name clozapine?
Gordon Tse, Deborah Thompson, Ric M Procyshyn
Schizophrenia Research
|
April 6, 2004
Clozapine's effects on body weight and resting metabolic rate: a case series
Ric M Procyshyn, Anthony Chau, Gordon Tse
BMJ Case Reports
|
February 13, 2025
Acute dystonia following the two-injection start of aripiprazole once-monthly
Alexander Levit, Ric M Procyshyn, Kamyar Keramatian
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
December 14, 2002
The influence of dyslipidemia on the plasma protein and lipoprotein distribution of haloperidol
Ric M Procyshyn, Gina Tsai, Kishor M Wasan
Drug Development and Industrial Pharmacy
|
August 12, 2005
Competitive displacement of clozapine from plasma proteins in normolipidemic and hyperlipidemic plasma samples: clinical implications
Ric M Procyshyn, Tiffany Ho, Kishor M Wasan
Schizophrenia Research
|
February 27, 2004
Smoking, anticholinergics and schizophrenia
Ric M Procyshyn, Kaleena Patel, Deborah L Thompson
Drug Development and Industrial Pharmacy
|
November 25, 2005
The effects of competitive displacement on haloperidol's plasma distribution in normolipidemic and hyperlipidemic plasma
Ric M Procyshyn, Tiffany Ho, Kishor M Wasan
Journal of Psychiatry & Neuroscience : JPN
|
December 21, 2011
Adverse events associated with switching antipsychotics
Johnny Su, Alasdair M Barr, Ric M Procyshyn
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
January 15, 2002
Concomitant clozapine reduces smoking in patients treated with risperidone
Ric M Procyshyn, Gordon Tse, Osric Sin, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
October 27, 2004
Prevalence and outcomes of pharmaceutical industry-sponsored clinical trials involving clozapine, risperidone, or olanzapine
Ric M Procyshyn, Anthony Chau, Patricia Fortin, et al.
Page
of 14